Allan Camaisa

About

Allan Camaisa is based out of Rancho Santa Fe, California, and is on the Board of Directors of Calidi Biotherapeutics. Previously, he served as the Chairman and CEO of Calidi Biotherapeutics, he has made a number of advancements, including a partnership with the U.S. NIH, recruitment of a Scientific Advisory Board, and the engagement of license negotiations with large pharmaceutical organizations, among others. Several years ago, Mr. Camaisa lost his own father to cancer; a tragedy that inspired him to co-found Calidi and make it his personal mission to bring to market a cure for difficult-to-treat cancers. Previously, Mr. Camaisa was the CEO and Chairman of Parallel6, Inc., a creator of a digital mobile software platform that engaged clinical trial participants and powered the enrollment, management, and retention of those participants on behalf of pharmaceutical organizations. Parallel6 was sold to PRA Health Sciences in 2017. Their clients included Sanofi, STSI/Genentech, Johnson &

Investment Focus

Location

Rancho Santa Fe, US